Impact of ablation index settings on pulmonary vein reconnection.


Journal

Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing
ISSN: 1572-8595
Titre abrégé: J Interv Card Electrophysiol
Pays: Netherlands
ID NLM: 9708966

Informations de publication

Date de publication:
Jan 2022
Historique:
received: 13 11 2020
accepted: 11 01 2021
pubmed: 12 2 2021
medline: 15 1 2022
entrez: 11 2 2021
Statut: ppublish

Résumé

Ablation index (AI) is a radiofrequency lesion quality marker. The AI value that allows effective and safe pulmonary vein isolation (PVI) is still debated. We evaluated the incidence of acute and late PV reconnection (PVR) with different AI settings and its predictors. The Ablation Index Registry is a multicenter study that included patients with paroxysmal/persistent atrial fibrillation (AF) who underwent first-time ablation. Each operator performed the ablation using his preferred ablation catheter (ThermoCool® SmartTouch or Surround Flow) and AI setting (380 posterior-500 anterior and 330 posterior-450 anterior). We divided the study population into two groups according to the AI setting used: group 1 (330-450) and group 2 (380-500). Incidence of acute PVR was validated within 30 min after PVI, whereas the incidence of late PVR was evaluated at repeat procedure. Overall, 490 patients were divided into groups 1 (258) and 2 (232). There was no significant difference in the procedural time, fluoroscopy time, and rate of the first-pass PVI between the two study groups. Acute PVR was observed in 5.6% PVs. The rate of acute PVR was slightly higher in group 2 (64/943, 6.8%, PVs) than in group 1 (48/1045, 4.6% PVs, p = 0.04). Thirty patients (6%) underwent a repeat procedure and late PVR was observed in 57/116 (49%) PVs (number of reconnected PV per patient of 1.9 ± 1.6). A similar rate of late PVR was found in the two study groups. No predictors of acute and late PVR were found. Ablation with a lower range of AI is highly effective and is not associated with a higher rate of acute and late PVR. No predictors of PV reconnection were found.

Identifiants

pubmed: 33570717
doi: 10.1007/s10840-021-00944-w
pii: 10.1007/s10840-021-00944-w
doi:

Types de publication

Journal Article Multicenter Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

133-142

Informations de copyright

© 2021. Springer Science+Business Media, LLC, part of Springer Nature.

Références

Taghij P, El Haddad M, Philips T, Wolf M, Knecht S, Vandekerckhove Y, et al. Evaluation of a strategy aiming to enclose the pulmonary vein with contiguous and optimized radiofrequency lesion in paroxysmal atrial fibrillation. JACC Clin Electrophysiol. 2018;4:99–108.
doi: 10.1016/j.jacep.2017.06.023
Hussein A, Das M, Chaturvedi V, Asfour IK, Daryanani N, Morgan M, et al. Prospective use of ablation index targets improves clinical outcomes following ablation for atrial fibrillation. J Cardiovasc Electrophysiol. 2017;28:1037–47.
doi: 10.1111/jce.13281
Solimene F, Schillaci V, Shopova G, Urraro F, Arestia A, Iuliano A, et al. Safety and efficacy of atrial fibrillation ablation guided by ablation index module. J Interv Card Electrophysiol. 2019;54:9–15.
doi: 10.1007/s10840-018-0420-5
Dhillon G, Ahsan S, Honarbakhsh S, Lim W, Baca M, Graham A, et al. A multicentered evaluation of ablation at higher power guided by ablation index: establishing ablation targets for pulmonary vein isolation. J Cardiovasc Electrophysiol. 2019;30:357–65.
doi: 10.1111/jce.13813
Stabile G, Lepillier A, De Ruvo E, Scaglione M, Anselmino M, Sebag F, et al. Reproducibility of pulmonary vein isolation guided by the ablation index: 1-year outcome of the AIR registry. J Cardiovasc Electrophysiol. 2020;31:1694–701.
doi: 10.1111/jce.14531
Duytschaever M, Vijgen J, De Potter T, Scherr D, Van Herendael H, Knecht S, et al. Standardized pulmonary vein isolation workflow to enclose veins with contiguous lesions: the multicentre VISTAX trial. Europace. 2020;euaa157.
Solimene F, Lepillier A, De Ruvo E, Scaglione M, Anselmino M, Sebag FA, et al. Reproducibility of acute pulmonary vein isolation guided by the ablation index. Pacing Clin Electrophysiol. 2019;42:874–81. https://doi.org/10.1111/pace.13710 .
doi: 10.1111/pace.13710 pubmed: 31045257
Das M, Loveday JJ, Wynn GJ, Gomes S, Saeed Y, Bonnett LJ, et al. Ablation index, a novel marker of ablation lesion quality: prediction of pulmonary vein reconnection at repeat electrophysiology study and regional differences in target values. Europace. 2017;19:775–83.
pubmed: 27247002
Stabile G, Di Donna P, Schillaci V, Di Monaco A, Iuliano A, Caponi D, et al. Safety and efficacy of pulmonary vein isolation using a surround flow catheter with contact force measurement capabilities: a multicenter registry. J Cardiovasc Electrophysiol. 2017;28:762–7.
doi: 10.1111/jce.13227
Park CI, Lehrmann H, Keyl C, Schiebeling J, Allgeier J, Schurr P, et al. Mechanisms of Pulmonary Vein Reconnection After Radiofrequency Ablation of Atrial Fibrillation: The Deterministic Role of Contact Force and Interlesion Distance. Journal of Cardiovascular Electrophysiology. 2014;25(7):701–8.
Ullah W, Hunter RJ, Finlay MC, McLean A, Dhinoja MB, Sporton S, et al. Ablation index and surround flow catheter irrigation impedance-based appraisal in clinical ablation. J Am Coll Cardiol EP. 2017;3:1080–8.
El Haddad M, Taghji P, Phlips T, Wolf M, Demolder A, Choudhury R, et al. Determinants of acute and late pulmonary vein reconnection in contact force-guided pulmonary vein isolation: identifying the weakest link in the ablation chain. Circ Arrhythm Electrophysiol. 2017;10(4):e004867. https://doi.org/10.1161/CIRCEP.116.004867 .
doi: 10.1161/CIRCEP.116.004867 pubmed: 28381417
Lee SR, Choi EK, Lee EJ, Choe WS, Cha MJ, Oh S. Efficacy of the optimal ablation index-targeted strategy for pulmonary vein isolation in patients with atrial fibrillation: the OPTIMUM study results. J Interv Card Electrophysiol. 2019;55:171–81. https://doi.org/10.1007/s10840-019-00565-4 .
doi: 10.1007/s10840-019-00565-4 pubmed: 31102113
Calkins H, Hindricks G, Cappato R, Kim YH, Saad EB, Aguinaga L, et al. 2017 HRS/EHRA/ECAS/APHRS/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation. Heart Rhythm. 2017;14:e275–444. https://doi.org/10.1016/j.hrthm.2017.05.012 .
doi: 10.1016/j.hrthm.2017.05.012 pubmed: 28506916 pmcid: 6019327
Hocini M, Sanders P, Jaïs P, Weerasoriya R, Scavée C, Takahashi Y, et al. Prevalence of pulmonary vein disconnection after anatomical ablation for atrial fibrillation: consequences of wide atrial encircling of the pulmonary veins. Eur Heart J. 2005;26:696–704.
doi: 10.1093/eurheartj/ehi096
Phlips T, Taghji P, El Haddad M, Wolf M, Knecht S, Vandekerckhove Y, et al. Improving procedural and one-year outcome after contact force-guided pulmonary vein isolation: the role of interlesion distance, ablation index, and contact force variability in the ‘CLOSE’-protocol. Europace. 2018;20(FI_3):f419–27. https://doi.org/10.1093/europace/eux376 .
doi: 10.1093/europace/eux376 pubmed: 29315411
De Pooter J, Strisciuglio T, El Haddad M, Wolf M, Phlips T, Vandekerckhove Y, et al. Pulmonary vein reconnection no longer occurs in the majority of patients after a single pulmonary vein isolation procedure. JACC Clin Electrophysiol. 2019;5(3):295–305.
doi: 10.1016/j.jacep.2018.11.020
Arentz T, Macle L, Kalusche D, Hocini M, Jais P, Shah D, et al. Dormant pulmonary vein conduction revealed by adenosine after ostial radiofrequency catheter ablation. J Cardiovasc Electrophysiol. 2004;15:1041–7.
doi: 10.1046/j.1540-8167.2004.04031.x
Chen C, Li D, Ho J, Liu T, Li X, Wang Z, et al. Clinical implications of unmasking dormant conduction after circumferential pulmonary vein isolation in atrial fibrillation using adenosine: a systematic review and meta-analysis. Front. Physiol. 2019;9:1861.
doi: 10.3389/fphys.2018.01861
Rajappan K, Kistler PM, Earley MJ, Thomas G, Izquierdo M, Sporton SC, et al. Acute and chronic pulmonary vein reconnection after atrial fibrillation ablation: a prospective characterization of anatomical sites. Pacing Clin Electrophysiol. 2008;31:1598–605.
doi: 10.1111/j.1540-8159.2008.01232.x
Higashiya S, Yamaji H, Murakami T, Hina K, Kawamura H, Murakami M, et al. Adjunctive interpulmonary isthmus ablation has no added effects on atrial fibrillation recurrence. Open Heart. 2017;4:e000593.
doi: 10.1136/openhrt-2017-000593
Hoffmann P, Ramirez ID, Baldenhofer G, Stangl K, Mont L, Althoff TF. Randomized study defining the optimum target interlesion distance in ablation index-guided atrial fibrillation ablation. Europace. 2020;22:1480–6.
doi: 10.1093/europace/euaa147

Auteurs

A Lepillier (A)

Centre Cardiologique du Nord, St Denis, Paris, France.

T Strisciuglio (T)

Clinica Montevergine, Mercogliano, Avellino, Italy.
University of Naples Federico II, Naples, Italy.

E De Ruvo (E)

Policlinico Casilino, Roma, Italy.

M Scaglione (M)

Ospedale Cardinal Massaia, Asti, Italy.

M Anselmino (M)

A.O.U. Citta della Salute e della Scienza di Torino, Department of Medical Sciences, University of Turin, Turin, Italy.

F A Sebag (FA)

Institut Mutualiste Montsouris, Paris, France.

D Pecora (D)

Fondazione Poliambulanza, Brescia, Italy.

M M Gallagher (MM)

St George's Hospital, London, UK.

M Rillo (M)

Casa di Cura Villa Verde, Taranto, Italy.

G Viola (G)

Ospedale San Francesco, Nuoro, Italy.

E Pisanò (E)

Ospedale Vito Fazzi, Lecce, Italy.

S Abbey (S)

Hôpital Privé Du Confluent (HPCN), Nantes, France.

F Lamberti (F)

Ospedale Sant'Eugenio, Roma, Italy.

A Pani (A)

Ospedale di Lecco, Lecco, Italy.

G Zucchelli (G)

Azienda Ospedaliera Pisana, Pisa, Italy.

G Sgarito (G)

A.R.N.A.S. Civico Cristina Benfratelli, Palermo, Italy.

A De Simone (A)

Clinica San Michele, via Montella 16, 81024, Maddaloni, Caserta, Italy.

E Bertaglia (E)

Department of Cardiac, Thoracic, and Vascular Sciences, University of Padova, Padova, Italy.

F Solimene (F)

Clinica Montevergine, Mercogliano, Avellino, Italy.

Giuseppe Stabile (G)

Clinica Montevergine, Mercogliano, Avellino, Italy. gmrstabile@tin.it.
Clinica San Michele, via Montella 16, 81024, Maddaloni, Caserta, Italy. gmrstabile@tin.it.
Anthea Hospital, Bari, Italy. gmrstabile@tin.it.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH